Cardiovascular risk associated with celecoxib - The editorialists reply

被引：0

作者：

Psaty, BM ^{[1
]}

Furberg, CD

机构：

[1] Univ Washington, Seattle, WA 98101 USA

[2] Wake Forest Univ, Winston Salem, NC 27106 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 352卷 / 25期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2649 / 2650

页数：2

共 50 条

[21] APC trial stopped: increased risk of cardiovascular events with celecoxib
Reactions Weekly, 2005, 1033 (1) : 2 - 2
[22] Adjusted indirect comparison of celecoxib versus rofecoxib on cardiovascular risk
Lee, Young Ho
Ji, Jong Dae
Song, Gwan Gyu
RHEUMATOLOGY INTERNATIONAL, 2007, 27 (05) : 477 - 482
[23] Adjusted indirect comparison of celecoxib versus rofecoxib on cardiovascular risk
Lee, YH
Rho, YH
Choi, SJ
Ji, JD
Song, GG
ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S231 - S231
[24] Adjusted indirect comparison of celecoxib versus rofecoxib on cardiovascular risk
Young Ho Lee
Jong Dae Ji
Gwan Gyu Song
Rheumatology International, 2007, 27 : 477 - 482
[25] Lipoproteins and cardiovascular risk - Reply
Sniderman, AD
Furberg, CD
van Lennep, JER
Jungner, I
Walldius, G
LANCET, 2003, 361 (9373): : 1989 - 1989
[26] Rosiglitazone and cardiovascular risk - Reply
Psaty, Bruce M.
Furberg, Curt D.
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (09): : 940 - 940
[27] Cardiovascular disease risk - Reply
Wang, XL
Wilcken, DEL
NATURE MEDICINE, 1996, 2 (04) : 366 - 366
[28] Estimating cardiovascular risk - Reply
Weymiller, Audrey
Montori, Victor M.
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (01) : 111 - 111
[29] ESTROGENS AND CARDIOVASCULAR RISK - REPLY
RAYMOND, CA
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (04): : 518 - 518
[30] Transfusion in elderly patients with myocardial infarction. Editorialists reply
Bach, RG
Goodnough, LT
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (10): : 781 - 782

← 1 2 3 4 5 →